ProPhase Labs, Inc. - Common Stock (PRPH)
0.2633
-0.1615 (-38.02%)
Prophase Labs Inc is a biotechnology company focused on developing and commercializing innovative healthcare solutions, particularly in the fields of over-the-counter pharmaceuticals and medical devices
The company leverages its expertise in scientific research and product development to create high-quality consumer health products aimed at improving patient outcomes. Prophase Labs is dedicated to advancing health and wellness through its commitment to safety, efficacy, and accessibility, while actively pursuing opportunities in both established and emerging markets to expand its portfolio and reach.
Frequently Asked Questions
Is ProPhase Labs, Inc. - Common Stock publicly traded?
Yes, ProPhase Labs, Inc. - Common Stock is publicly traded.
What exchange does ProPhase Labs, Inc. - Common Stock trade on?
ProPhase Labs, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for ProPhase Labs, Inc. - Common Stock?
The ticker symbol for ProPhase Labs, Inc. - Common Stock is PRPH on the Nasdaq Stock Market
What is the current price of ProPhase Labs, Inc. - Common Stock?
The current price of ProPhase Labs, Inc. - Common Stock is 0.2633
When was ProPhase Labs, Inc. - Common Stock last traded?
The last trade of ProPhase Labs, Inc. - Common Stock was at 4:00 pm EST on January 31st, 2025
What is the market capitalization of ProPhase Labs, Inc. - Common Stock?
The market capitalization of ProPhase Labs, Inc. - Common Stock is 4.75M
How many shares of ProPhase Labs, Inc. - Common Stock are outstanding?
ProPhase Labs, Inc. - Common Stock has 18.05M shares outstanding.